EN FR

Certification monthly report of activities: End of November 2023

EDQM 07/12/2023 Strasbourg, France

The latest monthly activity report for the Certification of Substances Department (DCEP) is now available. End of November 2023 Certification Monthly Report For more information, access the Certification Database.

Read More

EN FR

Reminder: Use of EMA SPOR/OMS ORG_ID and LOC_ID mandatory for any CEP applications

EDQM 04/12/2023 Strasbourg, France

Since 1 June 2023, applicants must provide in the application forms for any type of submission (new dossiers, sister files, revisions and renewals) the EMA SPOR/OMS ORG_ID and LOC_ID (unique identifiers for an organisation and its locations) for all companies involved in Certification of...

Read More

EN FR

Certification monthly report of activities: End of October 2023

EDQM 10/11/2023 Strasbourg, France

The latest monthly activity report for the Certification of Substances Department (DCEP) is now available. End of October 2023 Certification Monthly Report For more information, access the Certification Database.

Read More

EN FR

CEP 2.0: new requirements for the content of the chemical purity and herbal drugs/herbal drug preparation dossiers

EDQM 09/11/2023 Strasbourg, France

The European Directorate for the Quality of Medicines & HealthCare (EDQM) wishes to provide further clarification regarding the presentation and content of the “Specification” section (3.2.S.4.1) to all applicants preparing an application in CEP 2.0 format. When completing section 3.2.S.4.1,...

Read More

EN FR

Certification monthly report of activities: End of September 2023

EDQM 06/10/2023 Strasbourg, France

The latest monthly activity report for the Certification of Substances Department (DCEP) is now available. End of September 2023 Certification Monthly Report For more information, access the Certification Database.

Read More

EN FR

CEP holders invited to comment on draft monographs published in Pharmeuropa 35.4

EDQM 06/10/2023 Strasbourg, France

Holders of Certificates of suitability to the monographs of the European Pharmacopoeia (CEPs) are requested to consult the list of substances for which draft revised monographs of the European Pharmacopoeia (Ph. Eur.) have been published in Pharmeuropa 35.4. The table below lists the substances...

Read More

EN FR

Implementation of the European Pharmacopoeia Supplement 11.4 – Notification for CEP holders

EDQM 06/10/2023 Strasbourg, France

Supplement 11.4 of the European Pharmacopoeia (Ph. Eur.) is now available. Holders of Certificates of suitability to the monographs of the Ph. Eur. (CEPs) are invited to update their applications according to the revised monographs that will be implemented on 1 April 2024, and to follow the...

Read More

EN FR

CEP 2.0 – Certificates of suitability: electronic signature features

EDQM 21/09/2023 Strasbourg, France

On 1 September 2023, the European Directorate for the Quality of Medicines & HealthCare (EDQM) implemented electronic signatures for CEPs and some other documents as part of the CEP 2.0 project. A document explaining the features of electronic signatures is now available on our website:...

Read More

EN FR

Changes to the acceptability of CEP applications for sterile grade materials

EDQM 21/09/2023 Strasbourg, France

The European Directorate for the Quality of Medicines & HealthCare (EDQM) is updating its policy concerning the acceptability of CEP applications for sterile active substances. Until now, acceptability requirements have applied to the manufacturing processes only when the manufacturer of the...

Read More

EN FR

CEP 2.0: Changes from September 2023 to information published in Certification Online and Knowledge databases

EDQM 07/09/2023 Strasbourg, France

The launch of CEP 2.0 will bring changes, beginning in September, to the information on CEPs published on the Certification Online and Knowledge databases. The tabulated data will now include additional columns showing SPOR ORG and LOC-ID information for the holder where this is available,* as...

Read More

EN FR

Certification monthly report of activities: End of August 2023

EDQM 06/09/2023 Strasbourg, France

The latest monthly activity report for the Certification of Substances Department (DCEP) is now available. End of August 2023 Certification Monthly Report For more information, access the Certification Database.

Read More

EN FR

EDQM at CPhI Worldwide 2023 – Book a one-to-one CEP consultation today

EDQM 01/09/2023 Strasbourg, France

The European Directorate for the Quality of Medicines & HealthCare (EDQM) will again be present at CPhI Worldwide – one of the international pharmaceutical industry’s biggest trade fairs – to be held in October this year. This event gives us an ideal occasion to connect with our clients and users...

Read More

EN FR

Certification monthly report of activities: End of July 2023

EDQM 07/08/2023 Strasbourg, France

The latest monthly activity report for the Certification of Substances Department (DCEP) is now available. End of July Certification Monthly Report For more information, access the Certification Database.

Read More

EN FR

CEP 2.0: The CEP letter of access is ready for use!

EDQM 24/07/2023 Strasbourg, France

The replacement of the declaration of access box on the CEP document by a separate letter of access is one of the changes introduced with the implementation of the CEP 2.0. The template for this letter is now finalised taking into account comments received during the public consultation. The CEP...

Read More

EN FR

Important update on N-nitrosamine impurities in substances covered by CEPs

EDQM 21/07/2023 Strasbourg, France

On 7 July 2023, the EMA published a revised version of the “Questions and answers for marketing authorisation holders/applicants on the CHMP Opinion for the Article 5(3) of Regulation (EC) No 726/2004 referral on nitrosamine impurities in human medicinal products”. This update includes new...

Read More

EN FR

CEP 2.0: implementation date

EDQM 19/07/2023 Strasbourg, France

The European Directorate for the Quality of Medicines & HealthCare (EDQM) is pleased to announce that the CEP 2.0 will be implemented on 1 September 2023. From that date onwards, new dossier applications and renewal applications will receive a CEP 2.0, whereas revision applications will receive a...

Read More

EN FR

Implementation of the European Pharmacopoeia Supplement 11.3 – Notification for CEP holders

EDQM 17/07/2023 Strasbourg, France

Supplement 11.3 of the European Pharmacopoeia (Ph. Eur.) is now available. Holders of Certificates of suitability to the monographs of the Ph. Eur. (CEPs) are invited to update their applications according to the revised monographs that will be implemented on 1 January 2024, and to follow the...

Read More

EN FR

CEP holders invited to comment on draft monographs published in Pharmeuropa 35.3

EDQM 17/07/2023 Strasbourg, France

Holders of Certificates of suitability to the monographs of the European Pharmacopoeia (CEPs) are requested to consult the list of substances for which draft revised monographs of the European Pharmacopoeia (Ph. Eur.) have been published in Pharmeuropa 35.3. The table below lists the substances...

Read More

EN FR

Certification monthly report of activities: End of June 2023

EDQM 07/07/2023 Strasbourg, France

The latest monthly activity report for the Certification of Substances Department (DCEP) is now available. End of June 2023 Certification Monthly Report For more information, access the Certification Database.

Read More

EN FR

2022 Highlights – EDQM annual report now available

EDQM 05/06/2023 Strasbourg, France

The European Directorate for the Quality of Medicines & HealthCare (EDQM) has published its 2022 annual report, providing a comprehensive overview of its activities and achievements, and putting select data on the present state of EDQM/Council of Europe public health initiatives at your...

Read More